Search Results - "Boch, Katharina"
-
1
Paradoxical improvement of life quality in the COVID-19 era in psoriasis patients
Published in PloS one (27-09-2022)“…BackgroundPsoriasis is a chronic immune-mediated inflammatory disease. Beyond the physical dimensions, the disease has an extensive emotional and psychosocial…”
Get full text
Journal Article -
2
Paradoxical improvement of life quality in the COVID-19 era in psoriasis patients
Published in PloS one (27-09-2022)“…Background Psoriasis is a chronic immune-mediated inflammatory disease. Beyond the physical dimensions, the disease has an extensive emotional and psychosocial…”
Get full text
Journal Article -
3
Lichen Planus
Published in Frontiers in medicine (01-11-2021)“…Lichen planus (LP) is a T cell-mediated disease affecting the stratified squamous epithelia of the skin and/or mucus membrane. Histologically, the disease is…”
Get full text
Journal Article -
4
Retrospective analysis of the clinical characteristics and patient‐reported outcomes in vulval lichen planus: Results from a single‐center study
Published in Journal of dermatology (01-12-2021)“…Vulval lichen planus (VLP) is a rare, but often chronic, inflammatory disease whose symptoms include genital pain, discomfort, and dyspareunia. The clinical…”
Get full text
Journal Article -
5
Milestones in Personalized Medicine in Pemphigus and Pemphigoid
Published in Frontiers in immunology (11-01-2021)“…Pemphigus and pemphigoid diseases are autoimmune bullous diseases characterized and caused by autoantibodies targeting adhesion molecules in the skin and/or…”
Get full text
Journal Article -
6
Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
Published in Frontiers in medicine (09-06-2022)“…An estimated 20-25% of the population is affected by chronic, non-communicable inflammatory skin diseases. Chronic skin inflammation has many causes. Among the…”
Get full text
Journal Article -
7
Dupilumab in Inflammatory Skin Diseases: A Systematic Review
Published in Biomolecules (Basel, Switzerland) (31-03-2023)“…Dupilumab was first approved for the treatment of atopic dermatitis (AD) and blocks the signaling of interleukin (IL)-4 and -13. Several other chronic skin…”
Get full text
Journal Article -
8
Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice
Published in PloS one (03-11-2021)“…Pemphigus vulgaris (PV) is a rare autoimmune blistering disease characterized by the development of autoantibodies targeting desmoglein (Dsg) 3, but also…”
Get full text
Journal Article -
9
Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris
Published in Acta dermato-venereologica (13-12-2022)“…Abstract is missing (Short communication)…”
Get full text
Journal Article -
10
Increased Fibrosis in a Mouse Model of Anti-Laminin 332 Mucous Membrane Pemphigoid Remains Unaltered by Inhibition of Aldehyde Dehydrogenase
Published in Frontiers in immunology (07-02-2022)“…Mucous membrane pemphigoid (MMP) is an autoimmune blistering disease characterized by autoantibodies against the basal membrane zone of skin and surface-close…”
Get full text
Journal Article -
11
Challenge of hepatitis B testing following intravenous immunoglobulin therapy in patients with autoimmune skin diseases
Published in Journal of dermatology (01-10-2022)“…Intravenous immunoglobulin (IVIg) contains pooled immunoglobulins from the plasma of healthy blood donors. All plasma samples are tested for HIV, hepatitis…”
Get full text
Journal Article -
12
Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris
Published in Acta dermato-venereologica (25-03-2022)“…Abstract is missing (Short communication)…”
Get full text
Journal Article -
13
Ring-shaped plaque on the face
Published in Skin health and disease (01-10-2023)“…Granulomatosis Miescher is a very rare, chronic, granulomatous (non-necrobiotic) disease. Clinical characteristics are a slowly centrifugally growing brownish…”
Get full text
Journal Article -
14
Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
Published in Frontiers in immunology (28-09-2022)“…Chronic blistering at the skin and/or mucous membranes, accompanied by a varying degree of inflammation, is the clinical hallmark of pemphigoid diseases that…”
Get full text
Journal Article -
15
Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
Published in Frontiers in immunology (30-11-2022)“…[This corrects the article DOI: 10.3389/fimmu.2022.865241.]…”
Get full text
Journal Article -
16
Surgery followed by 585 nm pulsed‐dye laser therapy in the treatment of granuloma faciale
Published in Skin health and disease (01-08-2023)“…Granuloma faciale is a rare, benign skin disease characterised by solitary or multiple papules, plaques or nodules, most often occurring on the face. The skin…”
Get full text
Journal Article -
17
Evaluation of clinical and laboratory characteristics of patients with cutaneous sarcoidosis: A single-center retrospective cohort study
Published in Frontiers in medicine (10-10-2022)“…Background Cutaneous sarcoidosis is a relatively rare disease whose clinical manifestations include red-brown macules, plaques, papules and subcutaneous…”
Get full text
Journal Article -
18
Alterations of Total Serum Immunoglobulin Concentrations in Pemphigus and Pemphigoid: Selected IgG2 Deficiency in Bullous Pemphigoid
Published in Frontiers in medicine (02-09-2020)“…Pemphigus and pemphigoid diseases are organ-specific autoimmune diseases of the skin and/or mucous membranes, which are caused by autoantibodies targeting…”
Get full text
Journal Article -
19
Topical Application of the PI3Kβ-Selective Small Molecule Inhibitor TGX-221 Is an Effective Treatment Option for Experimental Epidermolysis Bullosa Acquisita
Published in Frontiers in medicine (07-09-2021)“…Class I phosphoinositide 3-kinases (PI3K) have been implemented in pathogenesis of experimental epidermolysis bullosa acquisita (EBA), an autoimmune skin…”
Get full text
Journal Article -
20
Serum Troponin T Concentrations Are Frequently Elevated in Advanced Skin Cancer Patients Prior to Immune Checkpoint Inhibitor Therapy: Experience From a Single Tertiary Referral Center
Published in Frontiers in medicine (05-07-2021)“…Immune checkpoint inhibitor (ICI) therapy has revolutionized the treatment of several human malignancies, particularly metastatic skin cancer. However,…”
Get full text
Journal Article